Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Q1 2021 Castle Biosciences Inc Earnings Call Transcript

May 10, 2021 / 08:30PM GMT
Release Date Price: $54.78 (-9.18%)
Operator

Good afternoon, and welcome to Castle Biosciences First Quarter 2021 Conference Call. As a reminder, today's call is being recorded. (Operator Instructions)

I would like to turn the call over to Camilla Zuckero, Executive Director, Investor Relations and Corporate Communications. Please go ahead.

Camilla Zuckero

Thank you, operator. Good afternoon, everyone. Welcome to Castle Biosciences First Quarter 2021 Financial Results Conference Call. Joining me today is Castle's Founder, President and Chief Executive Officer, Derek Maetzold; and Chief Financial Officer, Frank Stokes.

Information recorded on this call speaks only as of today, May 10, 2021. Therefore, if you are listening to the replay or reading the transcript of this call, any time-sensitive information may no longer be accurate. A recording of today's call will be available on the Investor Relations page of the company's website for approximately 3 weeks.

Before we begin, I would like to remind you that some of the information discussed today may contain projections or other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot